NASDAQ : NEOG
Neogen Corporation — Key statistics
Healthcare · Medical Devices · United States
Last price 11.82 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.58B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.60B |
| Enterprise Value | 3.20B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 6, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 218.31M |
| Shares Outstanding | 218.31M |
| Shares Change (YoY) | +0.32% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 0.46% |
| Owned by Institutions (%) | 110.91% |
| Float | 217.25M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 35.00 |
| PS Ratio | 2.94 |
| Forward PS | 2.99 |
| PB Ratio | 1.24 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 52.25 |
| P/OCF Ratio | 30.51 |
| PEG Ratio | 3.48 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 3.63 |
| EV / EBITDA | 29.40 |
| EV / EBIT | n/a |
| EV / FCF | 64.35 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.90 |
| Quick Ratio | 2.06 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | 6.73 |
| Debt / FCF | 15.55 |
| Interest Coverage | -0.13 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -2.67% |
| Return on Assets (ROA) | -0.14% |
| Return on Invested Capital (ROIC) | -0.27% |
| Return on Capital Employed (ROCE) | -0.23% |
| Weighted Average Cost of Capital (WACC) | 12.18% |
| Revenue Per Employee | $335,357 |
| Profits Per Employee | -$21,282 |
| Employee Count | 2,636 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 2.74 |
Taxes
| Measure | Value |
|---|
| Income Tax | -11.60M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.79 |
| 52-Week Price Change | +94.00% |
| 50-Day Moving Average | 12.23 |
| 200-Day Moving Average | 10.43 |
| Relative Strength Index (RSI) | 47.60 |
| Average Volume (20 Days) | 3,653,781 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 11.93M |
| Short Previous Month | 11.85M |
| Short % of Shares Out | 5.46% |
| Short % of Float | 5.49% |
| Short Ratio (days to cover) | 2.26 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 884.00M |
| Gross Profit | 419.00M |
| Operating Income | -7.30M |
| Pretax Income | -67.70M |
| Net Income | -56.10M |
| EBITDA | 109.00M |
| EBIT | -7.30M |
| Loss Per Share | -$0.26 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 172.00M |
| Total Debt | 774.30M |
| Net Cash | -602.30M |
| Net Cash Per Share | -$2.76 |
| Equity (Book Value) | 2.09B |
| Book Value Per Share | 9.56 |
| Working Capital | 433.00M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 85.30M |
| Capital Expenditures | -35.50M |
| Depreciation & Amortization | 116.30M |
| Net Borrowing | -20.00M |
| Free Cash Flow | 49.80M |
| FCF Per Share | $0.23 |
Margins
| Measure | Value |
|---|
| Gross Margin | 47.40% |
| Operating Margin | -0.83% |
| Pretax Margin | -7.66% |
| Profit Margin | -6.35% |
| EBITDA Margin | 12.33% |
| EBIT Margin | -0.83% |
| FCF Margin | 5.63% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.32% |
| Shareholder Yield | -0.32% |
| Earnings Yield | -2.18% |
| FCF Yield | 1.91% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $14.00 |
| Price Target Difference | 17.75% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | -0.15% |
| EPS Growth Forecast (3Y) | 24.67% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jun 7, 2021 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.1 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |